Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Dana J. Lukin, David M. Faleck, Ronghui Xu, Yiran Zhang, Aaron Weiss, Satimai Aniwan, Siri Kadire, Gloria Tran, Mahmoud Rahal, Adam C. Winters, Shreya Chablaney, Jenna L. Koliani‐Pace, Joseph Meserve, James P. Campbell, Gursimran Kochhar, Matthew Bohm, Sashidhar Varma, Monika Fischer, Brigid S. Boland, Siddharth Singh, Robert Hirten, Ryan C. Ungaro, Karen Lasch, Eugenia Shmidt, Vipul Jairath, David Hudesman, Shannon Chang, Arun Swaminath, Bo Shen, Sunanda V. Kane, Edward V. Loftus, Bruce E. Sands, Jean‐Frédéric Colombel, Corey A. Siegel, William J. Sandborn, Parambir S. Dulai